FDA Inspection 1306620 — Mark Galantowicz, MD
The FDA completed an inspection of Mark Galantowicz, MD on February 27, 2026 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 27, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Columbus, OH (United States)
Additional Details
Clinical Investigator (CI)